BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31529849)

  • 21. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
    Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clostridium difficile infections at Landspítali - 1998-2008].
    Kvaran RB; Valsdóttir EB; Sigurdsson HK; Gottfredsson M
    Laeknabladid; 2010 Sep; 96(9):523-9. PubMed ID: 20820068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diversity of multidrug-resistant epidemic Clostridium difficile NAP1/RT027/ST01 strains in tertiary hospitals from Honduras.
    Hidalgo-Villeda F; Tzoc E; Torres L; Bu E; Rodríguez C; Quesada-Gómez C
    Anaerobe; 2018 Aug; 52():75-78. PubMed ID: 29890209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile recurrences in Stockholm.
    Sandell S; Rashid MU; Jorup-Rönström C; Ellström K; Nord CE; Weintraub A
    Anaerobe; 2016 Apr; 38():97-102. PubMed ID: 26802875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.
    Hubert B; Loo VG; Bourgault AM; Poirier L; Dascal A; Fortin E; Dionne M; Lorange M
    Clin Infect Dis; 2007 Jan; 44(2):238-44. PubMed ID: 17173224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.
    Quesada-Gómez C; López-Ureña D; Acuña-Amador L; Villalobos-Zúñiga M; Du T; Freire R; Guzmán-Verri C; del Mar Gamboa-Coronado M; Lawley TD; Moreno E; Mulvey MR; de Castro Brito GA; Rodríguez-Cavallini E; Rodríguez C; Chaves-Olarte E
    J Clin Microbiol; 2015 Apr; 53(4):1216-26. PubMed ID: 25653402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NAP1 strain type predicts outcomes from Clostridium difficile infection.
    See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
    Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
    Chopra T; Alangaden GJ; Chandrasekar P
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1113-9. PubMed ID: 20954878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Clostridium difficile infection caused by the NAP1/RT027 strain on severity and recurrence during an outbreak and transition to endemicity in a Mexican tertiary care center.
    Tamez-Torres KM; Torres-González P; Leal-Vega F; García-Alderete A; López García NI; Mendoza-Aguilar R; Galindo-Fraga A; Bobadilla-Del Valle M; Ponce de León A; Sifuentes-Osornio J
    Int J Infect Dis; 2017 Dec; 65():44-49. PubMed ID: 28986313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007-2015.
    Tsai CS; Hung YP; Lee JC; Lee NY; Chen PL; Syue LS; Li MC; Li CW; Ko WC
    J Microbiol Immunol Infect; 2018 Apr; 51(2):243-250. PubMed ID: 28089100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
    Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
    Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027.
    Kociolek LK; Gerding DN
    J Clin Microbiol; 2016 Jan; 54(1):19-24. PubMed ID: 26511742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
    Tokimatsu I; Shigemura K; Osawa K; Kinugawa S; Kitagawa K; Nakanishi N; Yoshida H; Arakawa S; Fujisawa M;
    J Infect Chemother; 2018 Aug; 24(8):641-647. PubMed ID: 29685855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration.
    Giancola SE; Williams RJ; Gentry CA
    Clin Microbiol Infect; 2018 Aug; 24(8):877-881. PubMed ID: 29174729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea.
    Kyne L; Sougioultzis S; McFarland LV; Kelly CP
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):653-9. PubMed ID: 12452292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.
    Barbut F; Corthier G; Charpak Y; Cerf M; Monteil H; Fosse T; Trévoux A; De Barbeyrac B; Boussougant Y; Tigaud S; Tytgat F; Sédallian A; Duborgel S; Collignon A; Le Guern ME; Bernasconi P; Petit JC
    Arch Intern Med; 1996 Jul; 156(13):1449-54. PubMed ID: 8678714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027.
    Wieczorkiewicz JT; Lopansri BK; Cheknis A; Osmolski JR; Hecht DW; Gerding DN; Johnson S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):418-23. PubMed ID: 26525793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An epidemic, toxin gene-variant strain of Clostridium difficile.
    McDonald LC; Killgore GE; Thompson A; Owens RC; Kazakova SV; Sambol SP; Johnson S; Gerding DN
    N Engl J Med; 2005 Dec; 353(23):2433-41. PubMed ID: 16322603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of molecular methods in the diagnosis of Clostridium difficile infections].
    Dulny G; Nurzyńska G; de Walthoffen SW; Kraśnicka A; Młynarczyk G
    Med Dosw Mikrobiol; 2013; 65(2):111-8. PubMed ID: 24180138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.